.svg){kind=small}
Apr-2026
Sales
Trend
6-Month
Product Count
SKUs
Overview
Market Insights Snapshot
Kind Medicine's performance in the Tincture & Sublingual category in California saw a notable presence at the start of 2026. In January, the brand secured the 19th rank, indicating a solid foothold in the market. However, the subsequent months did not reflect the same momentum as Kind Medicine did not appear in the top 30 ranks from February through April. This absence could suggest increased competition or a shift in consumer preferences, potentially highlighting areas for improvement or strategic adjustment for the brand.
While the initial ranking in January was promising, the lack of presence in the top 30 in the following months underscores the challenges Kind Medicine might be facing in maintaining its market position. This trend could be indicative of a broader market dynamic where certain brands fail to sustain early gains. The sales figure for January was $15,956, but without subsequent data, it's challenging to determine the impact of these rankings on overall sales performance. Understanding these dynamics and market movements can provide valuable insights into the competitive landscape and consumer behavior in the Tincture & Sublingual category across California.
Competitive Landscape
In the California Tincture & Sublingual category, Kind Medicine experienced a notable shift in its competitive standing at the start of 2026. In January, Kind Medicine was ranked 19th, but it did not maintain a top 20 position in the subsequent months, indicating a potential decline in market presence. In contrast, High Power consistently held the 17th rank from February through April, showcasing stable performance and possibly capturing market share that Kind Medicine lost. Meanwhile, Breez improved its rank from 20th in January to 18th in February, suggesting an upward trend and increased competition for Kind Medicine. Casa Flor, which was not in the top 20 in January, reappeared at 19th in March, further intensifying the competitive landscape. These dynamics highlight the need for Kind Medicine to reassess its strategies to regain and sustain its market position in this category.
Notable Products
In April 2026, the top-performing product for Kind Medicine was the CBD/THC 25:1 Pet Tincture (500mg CBD, 20mg THC, 30ml) from the Tincture & Sublingual category, which rose to the first rank with sales of 33 units, up from its previous ranks of 4 and 5 in earlier months. The Indica Capsules 32-Pack (960mg) maintained a steady second position, showing consistent popularity. The CBD Clarity Tincture (1000mg CBD, 30ml) achieved third place, moving up from its fourth position in February. The CBD/THC 1:1 Kind Rub Moisture Roll-On (37.5mg CBD, 37.5mg THC, 25ml) entered the rankings for the first time at fourth position. The Menthol Formula Rub (150mg THC, 50ml) dropped to fourth place, a notable decline from its top position in March.
Top Selling Cannabis Brands
Data for this report comes from real-time sales reporting by participating cannabis retailers via their point-of-sale systems, which are linked up with Headset’s business intelligence software. Headset’s data is very reliable, as it comes digitally direct from our partner retailers. However, the potential does exist for misreporting in the instance of duplicates, incorrectly classified products, inaccurate entry of products into point-of-sale systems, or even simple human error at the point of purchase. Thus, there is a slight margin of error to consider. Brands listed on this page are ranked in the top twenty within the market and product category by total retail sales volume.
